Physician profile
Albert O Kwon
NPI 1225298722
$922.37
in general payments reported to CMS, 2019-2025
18 companies · $24.35 in 2025
The $24.35 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $86.72 · 2021: $222 · 2022: $183 · 2023: $145 · 2024: $33.80 · 2025: $24.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.34 | 2019-2022 | |
| Ethicon US, LLC | $145.62 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.44 | 2021-2024 | Entyvio |
| Braintree Laboratories, INC. | $73.57 | 2019-2023 | Sutab |
| Celgene Corporation | $72.36 | 2021-2023 | Zeposia |
| Abbvie INC. | $65.00 | 2021-2023 | |
| Medtronic USA, INC. | $48.50 | 2020 | |
| Janssen Biotech, INC. | $43.05 | 2022 | |
| Merck Sharp & Dohme LLC | $36.48 | 2023 | Dificid |
| Davol INC. | $28.25 | 2019 | |
| Boston Scientific Corporation | $24.35 | 2025 | General - Biliary Devices |
| Axonics, INC. | $17.69 | 2021 | |
| Lilly USA, LLC | $16.76 | 2024 | Omvoh |
| Ardelyx, INC. | $15.70 | 2023 | Ibsrela |
| Baudax Bio INC. | $15.00 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.89 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.69 | 2019 | |
| Thd America, INC. | $8.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.